The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy
- PMID: 21492158
 - PMCID: PMC3166398
 - DOI: 10.1111/j.1475-6773.2011.01263.x
 
The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy
Abstract
Objective: To determine whether biennial eye evaluation or telemedicine screening are cost-effective alternatives to current recommendations for the estimated 10 million people aged 30-84 with diabetes but no or minimal diabetic retinopathy.
Data sources: United Kingdom Prospective Diabetes Study, National Health and Nutrition Examination Survey, American Academy of Ophthalmology Preferred Practice Patterns, Medicare Payment Schedule.
Study design: Cost-effectiveness Monte Carlo simulation.
Data collection/extraction methods: Literature review, analysis of existing surveys.
Principal findings: Biennial eye evaluation was the most cost-effective treatment option when the ability to detect other eye conditions was included in the model. Telemedicine was most cost-effective when other eye conditions were not considered or when telemedicine was assumed to detect refractive error. The current annual eye evaluation recommendation was costly compared with either treatment alternative. Self-referral was most cost-effective up to a willingness to pay (WTP) of U.S.$37,600, with either biennial or annual evaluation most cost-effective at higher WTP levels.
Conclusions: Annual eye evaluations are costly and add little benefit compared with either plausible alternative. More research on the ability of telemedicine to detect other eye conditions is needed to determine whether it is more cost-effective than biennial eye evaluation.
© Health Research and Educational Trust.
Figures
              
              
              
              
                
                
                
              
              
              
              
                
                
                References
- 
    
- Age-Related Eye Disease Study Research Group. A Randomized, Placebo-Controlled Clinical Trial of High-Dose Supplementation with Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss. AREDS Report No. 8. Archives of Ophthalmology. 2001;119:1417–36. - PMC - PubMed
 
 - 
    
- Ahmed J, Ward TP, Bursell SE, Aiello LM, Cavallerano JD, Vigersky RA. The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy. Diabetes Care. 2006;29(10):2205–9. - PubMed
 
 - 
    
- American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern: Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008. - PubMed
 
 - 
    
- American Medical Association. CPT 2006: Current Procedural Terminology (Standard Edition) Florence, KY: Thomson Delmar Learning; 2007.
 
 - 
    
- Arias E. Miller DV. National Vital Statistics Reports. Hyattsville, MD: National Center for Health Statistics; 2007. United States Life Tables, 2004; pp. 1–40. - PubMed
 
 
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
